Jeff Yass’s Trinity Biotech TRIB Stock Holding History
Bought
Maintained
Sold
Other funds holding TRIB
Jeff Yass's TRIB Position: Q3 2026 in Review
Jeff Yass sold out of Trinity Biotech (TRIB) in Q3 2026, closing a stake of 895 shares — an estimated $8.9K sold.
Jeff Yass first reported a position in TRIB in Q3 2013 and held it in 25 quarters. The position peaked at $1.02M in Q2 2014. 10 funds tracked by Wall St. Rank hold TRIB as of Q3 2026.
- Jeff Yass reported no remaining Trinity Biotech position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 895 Trinity Biotech shares in Q3 2026, an estimated $8.9K.
- Jeff Yass first reported a position in Trinity Biotech in Q3 2013 and held it in 25 quarters.
- Jeff Yass's Trinity Biotech position peaked at $1.02M in Q2 2014.
- 10 funds tracked by Wall St. Rank held Trinity Biotech as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.